Needham Raises Glaukos Price Target to $251 From $201
Needham maintained its Buy rating on Glaukos and raised its price target to $251 from $201. The target implies 38.3% upside from the Oct. 28 close of $181.43.
Related stories
Exxon Mobil Q3 Adjusted Earnings Beat Estimates, Revenue Rises
Exxon Mobil reported Q3 adjusted earnings Friday; revenue rose.
M impact | EQUITY | Oct 30, 2026, 11:08 AM UTC
HSBC Upgrades GE Vernova to Buy, Raises Price Target to $1,100
HSBC raised its price target from $1,040 to $1,100, citing gas demand and a less risky outlook for the wind business.
H impact | EQUITY | Oct 30, 2026, 11:06 AM UTC
AstraZeneca Reports Third-Quarter Revenue of $16.21B
M impact | EQUITY | Oct 30, 2026, 11:05 AM UTC
BofA Securities Downgrades NMI Holdings to Neutral, Cuts Target to $44
BofA Securities lowered its price target from $51 to $44. The revised target implies 1.9% upside from the Oct. 29 close of $43.18.
M impact | EQUITY | Oct 30, 2026, 11:05 AM UTC
Citizens Financial Services Reports Unaudited Third-Quarter 2026 Results
M impact | EQUITY | Oct 30, 2026, 11:05 AM UTC
Hess Midstream Reports Q3 Revenue of $410.1M
Hess Midstream LP reported Q3 revenue of $410.1 million, versus FactSet estimates of $404.7 million.
M impact | EQUITY | Oct 30, 2026, 11:02 AM UTC